Comparison of plasma lipid profiles and atherogenic indices among hypertensives with or without type 2 diabetes
Michael Adeyemi Olamoyegun1, Oluwabukola Ayodele Ala2, Sandra Ozozehio Iwuala3, Bimbola Michael Fawale4
1 Department of Internal Medicine, Endocrinology, Diabetes and Metabolism Unit, College of Health Sciences, LAUTECH Teaching Hospital and Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria 2 Department of Medicine, College of Medicine, Bowen University and Bowen University Teaching Hospital, Ogbomoso, Oyo State, Nigeria 3 Department of Medicine, Endocrinology, Diabetes and Metabolism Unit, College of Medicine, University of Lagos, and Lagos University Teaching Hospital, Idi Araba, Lagos, Lagos State, Nigeria 4 Department of Medicine, College of Health Sciences, Obafemi Awolowo University and Obafemi Awolowo University Teaching Hospital Complex, Ile Ife, Osun State, Nigeria
Correspondence Address:
Dr. Michael Adeyemi Olamoyegun Department of Internal Medicine, Endocrinology, Diabetes and Metabolism Unit, College of Health Sciences, LAUTECH Teaching Hospital, Ladoke Akintola University of Technology, Ogbomoso, Oyo State Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/smj.smj_37_19
|
Background: Several atherogenic indices derived from the lipid profiles are postulated to better detect dyslipidemias and predict the risk of having cardiovascular events even in the presence of insignificant changes in individual lipid parameters. Objective: To compare the lipid ratios and atherogenic index of plasma (AIP) to conventional atherogenic indices among hypertensive type 2 diabetics to hypertensive nondiabetes (HND) controls. Materials and Methods: A case–control study in which 210 participants with type 2 diabetes mellitus with hypertension (hypertensive-diabetic [HD]) compared with 150 (n = 155) hypertensive without diabetes (HND) with similar ages were enrolled. Blood samples for fasting lipid profile were collected and analyzed, and the following indices and ratios were calculated: (TC/high-density lipoprotein-cholesterol [HDL-C]), (low-density lipoprotein-cholesterol [LDL-C]/HDL-C), (HDL-C/LDL-C), and AIP. The indices were compared in both the participants and control group. Results: There was no significant difference in the clinical characteristics of HD compared to the HND except the systolic blood pressure, weight, and HDL-C which were lower in the HND group. The frequency of dyslipidemia was found to be significantly higher in the HD group except elevated LDL-C in males (25.8% vs. 17.4%, χ2 = 0.055, respectively). Furthermore, all the lipid ratios, except (Castelli risk index II [CRI– II] were found to be significantly different among HD as compared to HND group (P = 0.002, P = 0.045, respectively). Conclusions: This study concludes that Nigerians with both type 2 diabetes and hypertension have worse dyslipidemia and abnormal lipid ratios compared to those with only hypertension.
|